Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Apigenin 6-c-glucosyl-7-o-glucoside
1. 20310-89-8
2. Isovitexin-7-o-glucoside
3. Saponaretin-7-o-glucoside
4. Petrocomoside
5. Isovitexin-7-o-beta-d-glucopyranoside
6. Isovitexin 7-o-glucoside
7. Apigenin 6-c-glucosyl-7-o-glucoside
8. 3081z76ox9
9. 4h-1-benzopyran-4-one, 6-.beta.-d-glucopyranosyl-7-(.beta.-d-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-
10. 5-hydroxy-2-(4-hydroxyphenyl)-6-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
11. Ac1l9b2g
12. Unii-3081z76ox9
13. Saponarin [mi]
14. 7-o-glucosylisovitexin
15. Isovitexin 7-glucoside
16. Schembl2489122
17. Chembl4640510
18. Chebi:75439
19. 7-o-(beta-d-glucosyl)isovitexin
20. Dtxsid10174201
21. Hy-n5083
22. Zinc4097454
23. Mfcd00238679
24. Akos037514829
25. Ccg-208416
26. Apigenin-6-c-glucoside -7-o-glucoside
27. Isovitexin 7-.beta.-d-glucoside
28. 5-hydroxy-2-(4-hydroxyphenyl)-6-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-7-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
29. 6-c-glucosyl-7-o-glucosylapigenin
30. Cs-0032401
31. Isovitexin 7-.beta.-d-glucopyranoside
32. C08064
33. Sr-05000002259
34. Sr-05000002259-2
35. Q63408652
36. (1s)-1,5-anhydro-1-[7-(beta-d-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-chromen-6-yl]-d-glucitol
37. 4h-1-benzopyran-4-one, 3-((6-o-(6-deoxy-beta-l-mannofuranosyl)-beta-o-galactofuranosyl)oxy)-7-((6-deoxy-beta-l-mannopyranosyl)oxy)-5-hydroxy-2-(4-hydroxyphenyl)-
38. 5-hydroxy-2-(4-hydroxyphenyl)-6-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)-7-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
39. 5-hydroxy-2-(4-hydroxyphenyl)-6-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]-7-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one
40. 6-.beta.-d-glucopyranosyl-7-(.beta.-d-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
Molecular Weight | 594.5 g/mol |
---|---|
Molecular Formula | C27H30O15 |
XLogP3 | -1.6 |
Hydrogen Bond Donor Count | 10 |
Hydrogen Bond Acceptor Count | 15 |
Rotatable Bond Count | 6 |
Exact Mass | 594.15847025 g/mol |
Monoisotopic Mass | 594.15847025 g/mol |
Topological Polar Surface Area | 256 Ų |
Heavy Atom Count | 42 |
Formal Charge | 0 |
Complexity | 971 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?